Pacira Pharmaceuticals makes appointments
This article was originally published in Scrip
Pacira Pharmaceuticals(US), an acute care speciality pharmaceutical company, has appointed Dr Gary Pace to its board of directors. Dr Pace is the founder and past chairman and CEO of QRx Pharma, and has also director and chairman positions for several speciality pharmaceutical companies. Pacira has also named Dr Bill Kirkpatrick, who has 30 years' medical regulatory and quality assurance experience, vice-president of compliance.